MARIETTA, Ga., July 17, 2026
BRIJ Medical has announced the commercial launch of BRIJ-SEAL™, an advanced wound sealant developed to improve post-operative incision management by providing surgeons with a fast, easy-to-apply solution that seals and protects surgical incisions using the company’s hypoallergenic adhesive technology. The new product expands BRIJ Medical’s growing incision management portfolio and is designed to deliver immediate incision sealing, 14-day bacterial protection, and enhanced patient comfort without disrupting existing surgical workflows. The launch reflects the company’s continued focus on developing innovative technologies that support optimal wound healing, reduce complications, and improve recovery following surgical procedures. BRIJ-SEAL can be used as a standalone incision protection device or integrated into a broader incision management strategy alongside the company’s Brijjit® active tension offloading system.
Advanced Wound Sealant Delivers Long-Lasting Incision Protection
BRIJ-SEAL™ has been engineered to provide a 14-day bacterial barrier, offering prolonged protection for surgical incisions during the critical early healing period. According to the company, the sealant features a hypoallergenic adhesive formulation that contains no glue and no cyanoacrylates, utilizing the same adhesive technology previously evaluated across six clinical trials without reported allergic reactions. The flexible wound sealant creates an immediate protective barrier while remaining breathable and waterproof, allowing moisture vapor to escape and enabling patients to shower under physician guidance. Designed for rapid clinical adoption, BRIJ-SEAL can be applied within seconds without adding additional procedural steps, helping surgeons streamline workflow while maintaining incision integrity and reducing the potential risk of surgical site infections.
Combined with Brijjit® for Comprehensive Incision Management
In addition to functioning as an independent wound sealant, BRIJ-SEAL™ can be paired with Brijjit®, BRIJ Medical’s active tension offloading device, to provide a more comprehensive approach to incision healing. While BRIJ-SEAL focuses on protecting the incision surface through immediate sealing and bacterial defense, Brijjit® is designed to reduce mechanical tension across healing wounds, a factor known to influence wound separation and scar formation. According to the company, clinical evidence from breast surgery studies has demonstrated that Brijjit® can eliminate up to 100% of incision tension, reduce wound breakdown by 90%, and decrease scar area by 38%. The combined use of both technologies enables surgeons to simultaneously reinforce wound closure, protect the incision, and optimize tissue healing throughout the recovery process.
Advertisement
Commercial Launch Strengthens BRIJ Medical’s Surgical Portfolio
The introduction of BRIJ-SEAL™ reinforces BRIJ Medical’s strategy of advancing incision management technologies that improve surgical outcomes from closure through recovery. The company stated that surgeons have increasingly requested solutions that are simple to use, comfortable for patients, and capable of delivering reliable incision protection without adhesive-related skin reactions. By expanding its product portfolio with a rapid-application wound sealant and integrating it with its clinically validated Brijjit® platform, BRIJ Medical aims to provide healthcare professionals with a comprehensive set of tools to enhance healing, reduce post-operative complications, and improve cosmetic outcomes. The commercial availability of BRIJ-SEAL™ marks another milestone in the company’s mission to advance surgical wound care through innovative, evidence-based incision management technologies.
Source: BRIJ Medical press release
